Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CATB - Audentes launches programs in DMD and DM1

CATB - Audentes launches programs in DMD and DM1

Catabasis Pharmaceuticals Inc.
  • Gene therapy developer Audentes Therapeutics (NASDAQ:BOLD) has expanded its pipeline with new programs in Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1).
  • More news on: Audentes Therapeutics, Inc., Sarepta Therapeutics, Inc., Solid Biosciences Inc., Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: Catabasis Pharmaceuticals Inc.
Stock Symbol: CATB
Market: NASDAQ
Website: catabasis.com
Menu
CATB CATB Quote CATB Short CATB News CATB Articles CATB Message Board
Get CATB Alerts

News, Short Squeeze, Breakout and More Instantly...